{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:39:20Z","timestamp":1791585560856,"version":"4.3.4"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Classic psychedelics are currently re-emerging as therapeutic agents with unique clinical benefits; however, it is also important to recognize the adverse effects of this drug class. While the risk of seizures with this drug class is known, the literature is lacking in detail. We present a case of psychedelic mushroom-induced seizures in a person with refractory right temporal lobe epilepsy implanted with a responsive neurostimulation (RNS) system. A large increase in typical seizure frequency coincided with the ingestion of a large dose of the mushrooms. This is the first reported case of electrographically confirmed seizures associated with classic psychedelic drug use. With the surge of research and movements toward the clinical application of classic psychedelic compounds, the risk for drug-induced seizures should be considered, including factors such as a history of epilepsy and drug doses and regimens.<\/jats:p>","DOI":"10.3389\/fneur.2023.1214969","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T22:11:15Z","timestamp":1688163075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Case report: Psychedelic-induced seizures captured by intracranial electrocorticography"],"prefix":"10.3389","volume":"14","author":[{"given":"Benjamin N.","family":"Blond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle A. D.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1126\/science.abn5486","article-title":"The therapeutic potential of psychedelics","volume":"378","author":"Schindler","year":"2022","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/epi.12998","article-title":"Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulator","volume":"56","author":"Quigg","year":"2015","journal-title":"Epilepsia."},{"key":"B3","first-page":"210","article-title":"Grand mal seizures following ingestion of LSD","volume":"106","author":"Fisher","year":"1967","journal-title":"Calif Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/jat\/bkaa145","article-title":"Severe neurological sequelae after a recreational dose of LSD","volume":"45","author":"Aaker\u00f8y","year":"2021","journal-title":"J Anal Toxicol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1177\/0269881118793086","article-title":"Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016","volume":"32","author":"Leonard","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13181-016-0593-1","article-title":"Ayahuasca exposure: descriptive analysis of calls to US poison control centers from 2005 to 2015","volume":"13","author":"Heise","year":"2017","journal-title":"J Med Toxicol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature","volume":"56","author":"Suzuki","year":"2015","journal-title":"Psychosomatics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"109586","DOI":"10.1016\/j.drugalcdep.2022.109586","article-title":"Prevalence and associations of classic psychedelic-related seizures in a population-based sample","volume":"239","author":"Simonsson","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"B9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamaneurol.2022.0829","article-title":"Efficacy and safety of fenfluramine for the treatment of seizures associated with lennox-gastaut syndrome: a randomized clinical trial","volume":"79","author":"Knupp","year":"2022","journal-title":"JAMA Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet."},{"key":"B11","first-page":"144P","article-title":"Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio)","volume":"40","author":"Meldrum","year":"1970","journal-title":"Br J Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0013-4694(71)90112-X","volume":"30","author":"Walter","year":"1971","journal-title":"Electroencephalogr Clin Neurophysiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.138.3545.1100","article-title":"Lysergic acid diethylamide: its effects on a male asiatic elephant","volume":"138","author":"West","year":"1962","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jobm.3620340104","article-title":"Extraction and analysis of indole derivatives from fungal biomass","volume":"34","author":"Gartz","year":"1994","journal-title":"J Basic Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory controlled study of the migraine-suppressing effects of psilocybin","volume":"18","author":"Schindler","year":"2021","journal-title":"Neurotherapeutics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/head.14420","article-title":"Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: results from a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Schindler","year":"2022","journal-title":"Headache."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002778","article-title":"Microdosing psilocybin for chronic pain: a case series","author":"Lyes","year":"2022","journal-title":"Pain."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1214969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T22:11:18Z","timestamp":1688163078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1214969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":17,"alternative-id":["10.3389\/fneur.2023.1214969"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1214969","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1214969"}}